NO20040007L - Anvendelse av 2,5-dihydroksybenzensulfonsyrederivater ved fremstilling av medikament for a fremme effekten av andre medikamenter ved behandling av erektil dysfunksjon - Google Patents

Anvendelse av 2,5-dihydroksybenzensulfonsyrederivater ved fremstilling av medikament for a fremme effekten av andre medikamenter ved behandling av erektil dysfunksjon

Info

Publication number
NO20040007L
NO20040007L NO20040007A NO20040007A NO20040007L NO 20040007 L NO20040007 L NO 20040007L NO 20040007 A NO20040007 A NO 20040007A NO 20040007 A NO20040007 A NO 20040007A NO 20040007 L NO20040007 L NO 20040007L
Authority
NO
Norway
Prior art keywords
medications
medicaments
efficacy
promote
manufacture
Prior art date
Application number
NO20040007A
Other languages
English (en)
Norwegian (no)
Inventor
Jose Esteve-Soler
Inigo Tejada-Forman
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO20040007L publication Critical patent/NO20040007L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20040007A 2001-07-02 2004-01-02 Anvendelse av 2,5-dihydroksybenzensulfonsyrederivater ved fremstilling av medikament for a fremme effekten av andre medikamenter ved behandling av erektil dysfunksjon NO20040007L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101535A ES2180446B1 (es) 2001-07-02 2001-07-02 Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil.
PCT/ES2002/000325 WO2003004097A1 (es) 2001-07-02 2002-07-01 Empleo de derivados de ácidos 2,5-dihidroxibencenosulfónicos en la elaboración de un medicamento para potenciar el efecto de otros fármacos en el tratamiento de la disfunción eréctil

Publications (1)

Publication Number Publication Date
NO20040007L true NO20040007L (no) 2004-02-23

Family

ID=8498259

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040007A NO20040007L (no) 2001-07-02 2004-01-02 Anvendelse av 2,5-dihydroksybenzensulfonsyrederivater ved fremstilling av medikament for a fremme effekten av andre medikamenter ved behandling av erektil dysfunksjon

Country Status (14)

Country Link
US (2) US20040143010A1 (enExample)
EP (1) EP1413332B1 (enExample)
JP (1) JP2005501031A (enExample)
AR (1) AR036124A1 (enExample)
AT (1) ATE419012T1 (enExample)
BR (1) BR0211315A (enExample)
CA (1) CA2453572A1 (enExample)
DE (1) DE60230629D1 (enExample)
ES (2) ES2180446B1 (enExample)
HU (1) HUP0400924A3 (enExample)
MX (1) MXPA04000007A (enExample)
NO (1) NO20040007L (enExample)
PL (1) PL367766A1 (enExample)
WO (1) WO2003004097A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2208123A1 (es) * 2002-11-29 2004-06-01 Laboratorios Del Dr. Esteve, S.A. Uso de los compuestos 2,5-dihidroxibencenosulfonicos para la fabricacion de un medicamento.
ES2222831B2 (es) * 2003-07-30 2006-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de principio activo que comprende un compuesto 2,5-dihidroxibencenosulfonico y un modulador de los canales de k+.
RU2281101C2 (ru) * 2004-10-01 2006-08-10 Юрий Михайлович Есилевский Способ лечения больных хроническим простатитом
EP1676573A1 (en) * 2004-12-30 2006-07-05 Laboratorios Del Dr. Esteve, S.A. Phamaceutical composition comprising a 2,5-dihydroxybenzenesulfonic-compound, a potassium ion channel modulator and a phosphodiesterase type 5 inhibitor
EP2669269B1 (en) 2005-05-27 2019-05-22 The University of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
EP2467173B8 (en) 2009-08-21 2019-06-19 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
CN109678764A (zh) * 2018-12-05 2019-04-26 湖北广辰药业有限公司 一种羟苯双磺酸及其钙盐和制备方法
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681503A (en) * 1970-04-17 1972-08-01 Om Lab Sa Method for combating disturbances of the lipid content of the blood
US4252821A (en) * 1979-12-07 1981-02-24 Laboratoires Om Societe Anonyme Method for treating ulcers
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
US4513007A (en) * 1983-05-03 1985-04-23 Laboratoires Om Sa Method for treating heart disease
RU1776408C (ru) * 1990-08-13 1992-11-23 Одесский Медицинский Институт Им.Н.И.Пирогова Способ лечени гломерулонефрита
AU715600B2 (en) * 1996-04-03 2000-02-03 Laboratorios Del Dr. Esteve, S.A. Use of 2,5-dihydroxybenzenesulfonic derivatives for the manufacture of medicaments intended for the normalization of the endothelial function, for the treatment of sexual dysfunction and vascular complications of diabetes, as well as vascular disorders of endothelial origin
HU225149B1 (en) * 1996-12-30 2006-07-28 Teva Gyogyszergyar Zrt Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance
US6403643B1 (en) * 1997-04-03 2002-06-11 Laboratories Del Dr. Esteve, S.A. Use of 2,5-dihydroxybenzenesulfonic derivatives for the normalization of endothelial function
US5994363A (en) * 1998-08-24 1999-11-30 Pentech Pharmaceuticals, Inc. Amelioration of apomorphine adverse effects
US6087362A (en) * 1999-03-16 2000-07-11 Pentech Pharmaceuticals, Inc. Apomorphine and sildenafil composition

Also Published As

Publication number Publication date
US20040143010A1 (en) 2004-07-22
ES2180446A1 (es) 2003-02-01
PL367766A1 (en) 2005-03-07
ES2180446B1 (es) 2004-01-16
HUP0400924A2 (hu) 2004-07-28
MXPA04000007A (es) 2004-05-21
ES2318023T3 (es) 2009-05-01
DE60230629D1 (de) 2009-02-12
CA2453572A1 (en) 2003-01-16
US20070197543A1 (en) 2007-08-23
ATE419012T1 (de) 2009-01-15
EP1413332A1 (en) 2004-04-28
AR036124A1 (es) 2004-08-11
EP1413332B1 (en) 2008-12-31
WO2003004097A1 (es) 2003-01-16
HUP0400924A3 (en) 2007-11-28
JP2005501031A (ja) 2005-01-13
BR0211315A (pt) 2004-09-28

Similar Documents

Publication Publication Date Title
NO2020007I1 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
PA8537901A1 (es) Derivados de eteres utiles como agentes inhibidores de las isozimas pde4
FR15C0069I2 (fr) Formulation a usage topique d'ivermectine pour le traitement de conditions dermatologiques
ZA200408649B (en) Opthamological use of roflumilast for the treatment of diseases of the eye
WO2002070510A3 (de) Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
PT1183029E (pt) Preparado farmaceutico contendo contendo o principio activo diamorfina e sua utilizacao num processo para o tratamento da dependencia de opiaceos
IL158289A (en) Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
WO2004041245A3 (en) Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
EE200300429A (et) Tegafuri, uratsiili, foliinhappe, paklitakseeli ja karboplatiini kasutamine ravimkoostise valmistamiseks kasvaja raviks
GB0204331D0 (en) Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
JP2002542248A5 (enExample)
NO20023486L (no) Forbindelser av pyrroltypen, perapater inneholdende forbindelser samt deres anvendelse for behandling av cancer- ogvirale sykdommer
AU3408901A (en) Cancer remedy comprising anthranilic acid derivative as active ingredient
SE0102440D0 (sv) New compound
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
HUP0400924A3 (en) Use of 2,5-dihydroxybenzenesulfphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction
CA2436511A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
WO2002092565A3 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
NO20043397L (no) Prucaloprid-N-oksid
AU2002317182A1 (en) Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction
WO2002022112A3 (en) Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application